Prostate cancer chemoprevention: models, limitations and potential (Review)

Area of Science:

• Oncology
• Cancer Research
• Preventive Medicine

Background:

• Prostate cancer's insidious nature and high mortality rate impede effective treatment development.
• There is a critical need for novel therapeutic strategies in prostate cancer management.
• Chemoprevention offers a promising approach by utilizing agents to inhibit or reverse carcinogenesis.

Purpose of the Study:

• To review existing research on chemopreventive and therapeutic agents for prostate cancer.
• To evaluate the efficacy of various compounds in preclinical prostate cancer models.
• To highlight the potential of chemoprevention in managing prostate cancer.

Main Methods:

• Comprehensive literature review of studies on prostate cancer chemoprevention.
• Analysis of in vitro (cell culture) and in vivo (animal) models.
• Evaluation of both natural and synthetic compounds as potential chemopreventive agents.

Main Results:

• Numerous compounds, both natural and synthetic, have shown promise in preclinical prostate cancer models.
• Chemoprevention strategies have demonstrated potential in delaying, halting, or reversing prostate carcinogenesis.
• The review synthesizes findings from diverse experimental systems.

Conclusions:

• Chemoprevention represents a viable and developing strategy for prostate cancer management.
• Further research into specific agents and their mechanisms is warranted.
• Preclinical models are crucial for identifying effective chemopreventive agents for prostate cancer.